While our own efforts focused on TNBC, we also reported MTBP expression is elevated in estrogen receptor positive (ER+) breast cancers as well as those expressing the receptor tyrosine kinase human epidermal growth factor receptor 2 (HER2) [8]. Here, ERBB2 is linked to breast cancer.